JPMorgan (NYSE:) Chase has made key leadership appointments in its healthcare and technology investment banking divisions. Ben Carpenter and Jeremy Meilman have been named global co-heads of healthcare investment banking, while in the technology sector, Chris Grose and Greg Mendelson will assume the roles of global co-heads.
The bank, which reported a 46% rise in investment banking revenues to $2.5 billion in the quarter to June, is strengthening its investment banking leadership as part of a broader strategy to capitalize on growing confidence in the U.S. economy and the associated upturn in capital raisings and acquisition deals.
Carpenter, an industry veteran, returned to JPMorgan in 2021 after a stint at Citigroup, where he focused on mergers and acquisitions (M&A) in the healthcare sector. Meilman has had a career at JPMorgan spanning nearly 20 years. Grose has been part of the JPMorgan team since 2005, while Mendelson, who joined the bank in 2015, most recently served as vice chair of investment banking.
In addition, Mike Gaito was appointed global chair of healthcare investment banking. Pankaj Goel, Madhu Namburi and Drago Rajkovic assume the positions of global chair of technology investment banking.
Doug Petno and Filippo Gori, co-heads of global banking at JPMorgan, expressed confidence in the new appointments: “Our clients and colleagues will benefit significantly from the extensive networks, strategic vision and profound market expertise of the new leaders.”
Reuters contributed to this article.
This translation was generated using artificial intelligence. For more information, please see our Terms of Use.
